Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Alejandra Garcia Novoa, Nicolasa Fernandez Soria, Jose Ignacio Rivas Polo, Alejandra Otero Ferreiro, Ignacio Rey Simo, Antón Fernandez García, Javier Aguirrezabalaga Gonzalez, Manuel Gomez Gutiérrez
Objective: To determine the viability of liver graft obtained from NHBD Maastricht II and III and long-term recipients survival. Material and Methods: Retrospective study of LT performed with en bloc technique for abdominal organ harvesting in NHBD in our hospital from December 1995 to January 2015. Results: 25 cases were performed: 17 Maastricht category II and 8 cases category III. Maastricht II. With a mean follow-up of 91.36 months (0,5-211m) one year recipient survival was 82.35% and 70.6% at 5 years. Liver graft survival was 70.6% and 64.7% at one year and five years, respectively. None of deaths during follow-up was secondary to graft failure. 3 patients were retransplanted: 2 were urgently for PAF and one at 3 years for HBV. Maastricht III. With a mean follow up of 14.67 months one year recipient survival was 100% and 88,9% of the graft survival. Two retransplantation were performed: one urgent for "small for size" and another at 18 months because of ischemic cholangitis. Conclusions: Grafts from NHBD allows acceptable results in terms of patient and graft survival.